Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2022

View Archived Issues

Extracellular domains are not effective targets to disrupt intracellular HER2-HER3 tumor signaling

CECR2 promotes breast cancer metastasis through NF-kappaB signaling and immunosuppression

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Monoclonal antibodies in AR-701 cocktail neutralize SARS-CoV-2 Omicron variant

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Merck & Co. presents new adenosine A2A and/or A2B receptor antagonists

New SREBP inhibitors identified at Capulus Therapeutics

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

New HSD17B13 inhibitors identified at Inipharm

Neurophilin-1 is an inhibitor of HIV-1 infectivity

Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody

Using photoactivatable peptide toxins for modulation of voltage-gated ion channels

Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis

Targeting GDNF may have potential to treat IBD

New biomarkers identified to predict response to vedolizumab in patients with Crohn's disease

Targeting PFKFB3 reduces the severity of colitis in mouse models

EBV antibodies put to good use through retargeting

Mindset reports new benchmarking data on first-generation psychedelics

Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...